EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A small molecule disrupts G4–STAT1 interaction and synergizes with olaparib to drive cancer cell death

Yingying Wang, Xuenan Zhang, Yuting Bian, Sihan He, Rongshuang Cheng, Jinzhu Li, Jonathan Dickerhoff iD, Yushuang Liu, Yu Zhou, Jinlei Bian, Kewei Zheng iD, Danzhou Yang iD und 2 weitere

Nucleic Acids Research · 05.05.2026 · 54 (9)

DOI: 10.1093/nar/gkag383 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nucleic Acids Research, online erschienen am 05.05.2026. Verfasst von Yingying Wang und 13 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Natural Medicines, Joint International Research Laboratory of Target Discovery and New Drug Innovation (Ministry of Education…. Hauptthemen laut MEDLINE: STAT1 Transcription Factor, Piperazines, Phthalazines, G-Quadruplexes. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Jiangsu Province, China Pharmaceutical University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Bloom syndrome protein (BLM), a RecQ family DNA helicase, is consistently overexpressed in multiple malignancies, yet its therapeutic potential remains largely unexplored. Herein, we focused on targeting the BLM promoter G-quadruplex (BLM-G4) to inhibit the BLM signaling pathway. We first characterized the parallel BLM-G4 in the BLM promoter region. Subsequently, it is shown for the first time that BLM-G4 recruits phosphorylated signal transducer and activator of transcription 1 (pSTAT1) to activate BLM expression. Importantly, two natural alkaloids, berberine (BER) and coptisine (COP), compete with STAT1 for binding to BLM-G4, thereby significantly suppressing BLM expression in colon cancer cells. The BER/COP−BLM-G4 complex structures were determined using nuclear magnetic resonance experiments, which provide valuable insights for the rational design of next-generation BLM-G4-targeting ligands. Beyond BLM regulation, the conjoint analysis of genome-wide STAT1-CUT&Tag-seq, G4-CUT&Tag-seq, and COP-RNA-seq demonstrated STAT1 as a general G4-binding transcription factor and COP as a pan-genomic G4 stabilizer. Furthermore, BER/COP exhibited a pronounced synergistic effect with olaparib in inducing colon cancer cell death by disrupting DNA repair pathways and intensifying DNA damage. Collectively, our findings reveal a novel epigenetic mechanism of BLM gene upregulation mediated by BLM-G4−STAT1 interaction and suggest that the combination therapy of G4 stabilizers with poly(ADP) ribose polymerase (PARP) inhibitors is a promising strategy for treating complex cancers.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

STAT1 Transcription FactorPiperazinesPhthalazinesG-QuadruplexesRecQ HelicasesHumansCell Line, TumorBerberineDrug SynergismPromoter Regions, GeneticCell DeathAntineoplastic AgentsGene Expression Regulation, NeoplasticSignal TransductionColonic NeoplasmsProtein Binding

Substanzen

STAT1 Transcription FactorolaparibPiperazinesPhthalazinesRecQ HelicasesSTAT1 protein, humanBerberineAntineoplastic Agents

Autor:innen und Institutionen

  • State Key Laboratory of Natural Medicines, Joint International Research Laboratory of Target Discovery and New Drug Innovation (Ministry of Education), and Jiangsu Key Laboratory of Bioactive Natural Product Research, C…
  • School of Biomedical Sciences, Hunan University, Changsha, Hunan 410082, PR China.
  • Department of Medicinal Chemistry and Molecular Pharmacology, Purdue University, West Lafayette, IN 47907, America.

ORCID-Profile: Jonathan Dickerhoff, Kewei Zheng, Danzhou Yang, Kai-Bo Wang

Förderung

  • National Natural Science Foundation of China
  • Natural Science Foundation of Jiangsu Province
  • China Pharmaceutical University
  • Fundamental Research Funds for the Central Universities

Zitieren

APA

Wang, Y., Zhang, X., Bian, Y., He, S., Cheng, R., Li, J., Dickerhoff, J., Liu, Y., Zhou, Y., Bian, J., Zheng, K., Yang, D., Kong, L. Y., & Wang, K. B. (2026). A small molecule disrupts G4–STAT1 interaction and synergizes with olaparib to drive cancer cell death. Nucleic Acids Research, 54(9). https://doi.org/10.1093/nar/gkag383

Vancouver

Wang Y, Zhang X, Bian Y, He S, Cheng R, Li J, et al. A small molecule disrupts G4–STAT1 interaction and synergizes with olaparib to drive cancer cell death. Nucleic Acids Research. 2026;54(9). doi:10.1093/nar/gkag383

BibTeX
@article{Wang2026,
  author = {Wang, Yingying and Zhang, Xuenan and Bian, Yuting and He, Sihan and Cheng, Rongshuang and Li, Jinzhu and Dickerhoff, Jonathan and Liu, Yushuang and Zhou, Yu and Bian, Jinlei and Zheng, Kewei and Yang, Danzhou and Kong, Ling-Yi and Wang, Kai-Bo},
  title = {A small molecule disrupts G4–STAT1 interaction and synergizes with olaparib to drive cancer cell death},
  journal = {Nucleic Acids Research},
  year = {2026},
  volume = {54},
  number = {9},
  doi = {10.1093/nar/gkag383}
}
Kostenlos starten →